Jasper Therapeutics JSPR
NASDAQ JSPR
$0.51 +0.01 (+1.88%)
As of: Oct 21, 2026 · 2:45 PM EDT

Jasper Therapeutics (JSPR) Debt Ratio (2022)

Updated

Jasper Therapeutics' Debt Ratio came in at 0.00 for Q4 2022.

Analysis

Jasper Therapeutics (JSPR) Debt Ratio (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn 0.39
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn 0.24
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn 0.52
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn 0.42
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn 0.08
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn 0.28
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn 0.60
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn 0.53
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn 0.31
10 Jasper Therapeutics 14.62 Mn -111.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 0.00
API Access

Jasper Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=JSPR&period=max&api_key=YOUR_API_KEY